Topic: Clinical Tools and Guidelines
STI Clinical Update Webinar – Introduction to Syphilis and Congenital Syphilis: A Phoenix IHS and CAPTC Event
January 11, 2024
8:30AM-12:00PM (MST)
Presented by CAPTC Clinical Faculty
Please note: CME not available for viewing the webinar recording.
Presenters:
- Sharon Adler, MD, MPH, Clinical Faculty, California Prevention Training Center
- Wyatt Hanft, MD, MPH, AAHIVS, STI Fellow, California Prevention Training Center
- Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
- Ina Park, MD, MS, Principal Investigator, California Prevention Training Center
- Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
- Moderator: Kelly Johnson, MD, MPH, Medical Director, California Prevention Training Center
Learning Objectives:
Describe the varied clinical manifestations of syphilis in adults & congenital syphilis (CS) in infants
Recognize that there are two different screening algorithms used to diagnose syphilis in adults
Define adequate treatment for syphilis, including during pregnancy
List at least 3 strategies to prevent syphilis in adults and infants
S4 E9 From Red Ribbons to Leather Straps: Rodney McCoy’s Trailblazing Tale of HIV Prevention and Pleasure

In this episode, Rodney McCoy, a Black queer man with over four decades of experience in HIV prevention and education, shares his journey as a Leatherman of color and discusses the intersection of BDSM, kink, and HIV prevention. From his entry into the kink community to becoming a titleholder in the American Leatherman competition, Rodney emphasizes how the kink community provided a safe space for self-discovery and empowerment. The episode explores the link between pleasure, power dynamics, and HIV prevention, highlighting the importance of honest conversations, sex positivity training, and the destigmatization of “risky behavior.”
Rodney, a health educator, program director, adjunct professor, and researcher, emphasizes the partnership between healthcare professionals and patients in promoting sexual health. Rodney says, “I am about encouraging people to embrace all pleasure: sexual pleasure, pleasure that comes from good mental health, from good physical health and from good social connections. I believe as healthcare professionals, regardless of the field we’re in, we are arbiters to help assist our clients explore and enhance that pleasure, that good health in their lives.” Rodney shares personal experiences as an HIV/STI testing specialist, addressing the impact of stigma and the importance of open communication.
Download the transcript of this episode.
Resources from Rodney:
Beyond the Red Ribbon training & other services: https://rodneymccoy.info/services
Listen to Daddy Podcast on YouTube
Bio:
Rodney “Rod” McCoy, Jr. brings his expertise of nearly four decades in HIV prevention and education, as well as his real-life experience as an African American gay/queer man living with HIV. An Oberlin College graduate with his Bachelors in Sociology and Black Studies, Rod has worked in a variety of capacities in the field of HIV Prevention, from Health Educator and HIV Counselor to Program Director. As an Adjunct Professor at George Mason University, Rod established the “HIV, Culture and Sexuality” course for the school’s Global and Community Health Department. Rod created a sex positivity training for public health professionals called Beyond the Red Ribbon in collaboration with Louis Shackelford of the HIV Vaccine Trials Network. He currently works at Us Helping Us in Washington, DC, as a Research Assistant.
STI Expert Hour Webinar – Navigating the Bicillin L-A Shortage: A Conversation with PharmD Dr. Kathy Yang
January 31, 2024
12:00PM-1:15PM (PST)
1.25 CME units at no cost
Please note: No CME available for viewing the webinar recording.
Learning Objectives
- List at least 2 factors contributing to ongoing Bicillin L-A shortages
- Describe a framework for prioritizing Bicillin L-A when supplies are limited
- Name potential alternative treatments for syphilis in non-pregnant people
- Develop a decision-making process for the treatment of syphilis when standard guidelines cannot be followed or when data is insufficient.
Meet Our Expert: Kathy Yang, PharmD, MPH
Dr. Yang is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy and the Co-Vice Dean of Clinical Innovation and Entrepreneurship at the University of California, San Francisco School of Pharmacy. She is also an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in pharmacokinetic and pharmacodynamic optimization of the treatment of multi-drug resistant infections, particularly gram-negative bacteria such as Pseudomonas aeruginosa. For the past 3 years, Dr. Yang has focused her efforts on the clinical management of COVID-19.
2023 Hawai’i STI Clinical Update
October 17, 2023
9AM-5PM (HST)
Honolulu, HI / Virtual
1-day in-person and virtual training covering the following topics:
- Syphilis in Pregnancy
- Congenital Syphilis
- Gonorrhea (GC)/Chlamydia (CT), including extragenital testing
- Doxycycline Post-exposure prophylaxis (doxy-PEP), Expedited Partner Therapy (EPT)
- Dermatologic manifestations of STIs – Urethritis/Vaginitis (including syndromic management)
- Sexual assault and STIs
Presented by:
- Kelly Johnson, MD,MPH, Medical Director, California Prevention Training Center
- Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
- Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
- Alan Katz, MD, MPH, Staff Physician, Hawai’i State Department of Health
- Moderator: Breena Gaskov, BS, Outreach Epidemiological Specialist, Hawai’i State Department of Health
Learning Objectives
- Explain prenatal syphilis screening and treatment recommendations
- Describe the clinical and public health approaches to GC/CT prevention
- Summarize data from recent studies exploring the use of doxy PEP to prevent bacterial STIs
- Compare potential strategies for doxy-PEP implementation in clinical settings
- Recognize dermatologic signs of sexually transmitted infections (STIs)
- Delineate treatment approaches for syndromes suggestive of STIs
STI Clinical Update Humboldt County-Addressing the Rise of Syphilis: A Review of Clinical Management of Syphilis and Congenital Syphilis for Health Care Providers
Presented by Drs. Kathleen Jacobson and Wyatt Hanft
December 5, 2023
Learning Objectives:
- Apply California’s expanded syphilis screening recommendations
- Describe the stages of syphilis and the recommended treatment and follow up for people with syphilis
- Compare the traditional and reverse algorithm for syphilis screening
Please note: CME not offered for viewing the recording of the update
How to Prescribe Expedited Partner Therapy (EPT) for Sexually Transmitted Infections
Expedited Partner Therapy (EPT) is the clinical practice of treating sex partners of patients diagnosed with certain sexually transmitted infections (STIs) – including chlamydia (CT), gonorrhea (GC), and trichomoniasis – without the health care provider first examining the partner(s). EPT usually involves patient delivered partner therapy (PDPT), in which the patient delivers the medication or a prescription to their partner(s). While evaluating the partner and providing other needed health services would be ideal, this is often not feasible. EPT can be provided confidentially; it is effective, safe, acceptable to patients and partners, and helps to ensure timely partner treatment.
This resource contains information on how to prescribe EPT in California, including sample prescriptions, information on billing/reimbursement, and patient-facing materials.
For more information on EPT and why it should be prescribed, see “Expedited Partner Therapy (EPT) for Sexually Transmitted Infections: A Resource for California Health Care Providers – What is EPT and Why Should I Prescribe It?”

Examination and Interpretation of Wet Preparations of Vaginal Specimens

- In-person laboratory course onsite at the UC San Francisco campus
- Intended for practicing clinicians with prior wet mount experience and microscopy skills
- Capacity limited to 8 persons
The course begins with a fifteen minute didactic presentation on applicable issues of CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. This will be followed by a fifteen minute video that details through the microscope footage of findings on VWM including trichomads, yeast and clue cells associated with BV. The remaining two and one-half hours consists of experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). During this portion of the training, participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
Learning Objectives
- Practice proper preparation of saline and KOH specimens of vaginal fluid to increase viability of specimens for microscopic evaluation.
- Perform proper use of the light microscope to improve examination of saline and KOH wet mount specimens.
- Assess wet mount microscopy specimens to appropriately interpret findings that support diagnosis of vulvovaginal candidiasis, bacterial vaginosis or trichomoniaisis.
STI Clinical Update Webinar: California Mpox Update for Healthcare Providers – October 2023

Thursday, October 26, 2023
12:00 PM – 1:30 PM (PDT)
The California Department of Public Health (CDPH) continues to see statewide Mpox activity, including a large cluster in Los Angeles County. This webinar, presented by the California Prevention Training Center (CAPTC), features CDPH’s Mpox Clinical and Epidemiology teams, who will provide a clinical update and epidemiological overview of Mpox, and discuss new research findings relevant to primary care and other healthcare providers, including data on transmission, vaccine equity, and vaccine effectiveness. A question-and-answer session will follow.
Presented by:
Kayla Saadeh, MPH
Mpox Epidemiology Unit Lead
California Department of Public Health
Jessica Watson, MD, MPH
Mpox Public Health Medical Officer and Acting Clinical Lead
California Department of Public Health
Learning Objectives
- Identify the clinical and epidemiological factors leading to Mpox infection, transmission, and severity as well as treatment options.
- Apply the latest information and research on Mpox, including transmission characteristics, vaccine equity, and vaccine effectiveness, to your clinical practice to ensure patients are appropriately vaccinated, diagnosed, tested, and treated for Mpox.
Please note: CME not available for viewing the webinar recording.
What, how, and why to talk to your clients about Doxy-PEP.
